The rise of a grey market in India, where unsupervised doses are sold at exorbitant rates, demonstrates that excessive ...

Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

New drugs targeting weight loss and diabetes management such as Ozempic/Wegovy can help lower the number of young people impacted by type 2 diabetes, a paediatrician says. Diabete ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Trump team is negotiating with weight-loss drug makers to lower prices to $149 a month: report - Obesity drugs have become an ...

Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Changes in weight and waist circumference were monitored over 104 weeks, as well as any risk associated with major adverse ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...

Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.